86
Participants
Start Date
June 18, 2020
Primary Completion Date
December 1, 2022
Study Completion Date
December 1, 2022
Mary M. Gooley Hemophilia Center, Inc., Rochester
University of Pittsburgh, Pittsburgh
Comprehensive Hemophilia Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill
Ohio State University Medical Center Hemophilia Treatment Center, Columbus
Indiana Hemophilia and Thrombosis Center (IHTC), Indianapolis
Henry Ford Health System, Detroit
Comprehensive Center for Bleeding Disorders, Milwaukee, Milwaukee
Hemophilia Outreach Center Green Bay, Green Bay
Mayo Comprehensive Hemophilia Center, Rochester
Bleeding and Clotting Disorders Institute, Peoria
Gulf States Hemophilia and Thrombophilia Center, Houston
Utah Center for Bleeding and Clotting Disorders, Salt Lake City
Orthopaedic Institute for Children Hemophilia Program, Los Angeles
University of California, San Francisco, San Francisco
Maine Hemophilia and Thrombosis Center, Scarborough
Collaborators (1)
BioMarin Pharmaceutical
INDUSTRY
American Thrombosis and Hemostasis Network
NETWORK